Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Remote Monitored Systems Plc LSE:RMS London Ordinary Share GB00BFX0ZN92 ORD 0.01P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.90 105,081,412 16:35:29
Bid Price Offer Price High Price Low Price Open Price
1.90 2.00 2.05 1.80 2.05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 0.04 -0.54 -0.29 30
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:29 O 1,000,000 1.91 GBX

Remote Monitored Systems (RMS) Latest News

More Remote Monitored Systems News
Remote Monitored Systems Investors    Remote Monitored Systems Takeover Rumours

Remote Monitored Systems (RMS) Discussions and Chat

Remote Monitored Systems Forums and Chat

Date Time Title Posts
28/11/202016:57RMS Patented 99.99% virus killing Masks Troll free zone 461
28/11/202010:21RMS into the future7,441
26/11/202016:56RMS2,079
18/11/202019:10Remote Monitored Systems...@pharm2farm potential !165
18/11/202015:44profit8

Add a New Thread

Remote Monitored Systems (RMS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-11-27 18:27:491.911,000,00019,100.00O
2020-11-27 18:24:391.93774,87914,990.03O
2020-11-27 18:04:291.89800,00015,080.00O
2020-11-27 17:28:011.90384,3847,310.98O
2020-11-27 17:22:511.87886,04716,524.78O
View all Remote Monitored Systems trades in real-time

Remote Monitored Systems (RMS) Top Chat Posts

DateSubject
28/11/2020
08:20
Remote Monitored Systems Daily Update: Remote Monitored Systems Plc is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker RMS. The last closing price for Remote Monitored Systems was 1.90p.
Remote Monitored Systems Plc has a 4 week average price of 0.90p and a 12 week average price of 0.33p.
The 1 year high share price is 6.80p while the 1 year low share price is currently 0.16p.
There are currently 1,573,270,231 shares in issue and the average daily traded volume is 158,265,273 shares. The market capitalisation of Remote Monitored Systems Plc is £29,892,134.39.
26/11/2020
10:22
jungmana: This is what the directors said on Monday:"Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020."Simply put , the directors sold out because they believe RMS is too overvalued.
25/11/2020
11:26
jungmana: "Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020."
25/11/2020
08:17
jungmana: The directors effectively saying is overvalued;"Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020."
24/11/2020
15:49
jungmana: Directors say the share price is too high:"Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020."Simply put , the directors sold out because they believe RMS is too overvalued.
24/11/2020
09:13
pwhite73: bygdennis - "They've nothing left to make a dent!" Yes they have. TB and PR have sold BRH's entire holding in RMS. BRH may have a £17 million cash pile but unless they're going to return some of it to PI shareholders as dividends its meaningless to the PI shareholders. If the share price of RMS rises sharply and I mean moving back to 5p BRH share holders would no longer profit from this rise because their 25% holding is gone. This would be good for RMS shareholders because any investor who wanted a stake in the P2F mask would not buy BRH shares now only RMS. But here's the bad twist. TB and PR need to prove their decision to sell their entire holding in RMS when they did was the correct one so they have no incentive to issue any positive RNS announcements for RMS. Indeed a share price rise back to 5p and above is likely to backfire on them. Is this why there is no further updates?.
24/11/2020
08:01
jungmana: "Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020."Simply put , the directors sold out because they believe RMS is too overvalued.
24/11/2020
07:43
hamidahamida: Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F.( So they thought Rms was overpriced when they dumped all their holding!!)Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020.
24/11/2020
06:57
bmwman3: Yesterday's BRH SUCKING UP TO THEIR SHAREHOLDERS explaining why they sold out of RMS too early imho...........................The Board confirm that following a series of share sales the Company no longer has a holding in Remote Monitored Systems plc ("RMS"), as was announced on 18 November 2020. The original intention of the Board had been to hold the RMS shares received as consideration for the sale of Pharm2Farm Limited ("P2F") as stated in an announcement issued by the Company on 21 August 2020. The closing mid-market price of a RMS share on 20 August 2020 was 0.38p. However, in the interim, a separate and unrelated investment owned by the Company, Paraytec Limited, made progress requiring further significant capital commitment from the Company, as announced on 16 October 2020 and 10 November 2020. As a result of selling a part of the Company's holding in RMS, as announced on 9 November 2020, the Company was able to meet this funding requirement. The cash now allocated to this project is expected to be sufficient to take the project through to a point where the product is ready for commercial launch in the UK within the first half of 2021.Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020. As stated on that date, the Board will consider a variety of options for the use of the net proceeds and inform shareholders in due course and as appropriate. The gross proceeds from the sale of RMS shares were £17.42 million. The Board is currently consulting its advisers in order to ascertain what the net proceeds are expected to be taking into account the level of any tax payable and will inform shareholders in due course.
23/11/2020
17:02
kemche: "Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020. As stated on that date, the Board will consider a variety of options for the use of the net proceeds and inform shareholders in due course and as appropriate. The gross proceeds from the sale of RMS shares were £17.42 million. The Board is currently consulting its advisers in order to ascertain what the net proceeds are expected to be taking into account the level of any tax payable and will inform shareholders in due course." Thereafter the directors have decided to take a 3 month sojourn in Barbados in celebration at the wheeze. The directors also anticipate handsome rewards in terms of bonuses to be awarded once the booty has been thoroughly counted. They also wish to go on record to express their sincerest gratitude to all those that created the "significant demand".
23/11/2020
16:53
autisticllama: Mon, 23rd Nov 2020 16:37 RNS Number : 2264G Braveheart Investment Group plc 23 November 2020 23 November 2020 Braveheart Investment Group plc ("Braveheart" or the "Company") Further Re. Share transactions in Remote Monitored Systems plc The Board confirm that following a series of share sales the Company no longer has a holding in Remote Monitored Systems plc ("RMS"), as was announced on 18 November 2020. The original intention of the Board had been to hold the RMS shares received as consideration for the sale of Pharm2Farm Limited ("P2F") as stated in an announcement issued by the Company on 21 August 2020. The closing mid-market price of a RMS share on 20 August 2020 was 0.38p. However, in the interim, a separate and unrelated investment owned by the Company, Paraytec Limited, made progress requiring further significant capital commitment from the Company, as announced on 16 October 2020 and 10 November 2020. As a result of selling a part of the Company's holding in RMS, as announced on 9 November 2020, the Company was able to meet this funding requirement. The cash now allocated to this project is expected to be sufficient to take the project through to a point where the product is ready for commercial launch in the UK within the first half of 2021. Thereafter it became apparent that there was significant demand from the market for shares in RMS at a valuation significantly above the expectations of the Directors at the time of the sale of P2F. The Directors concluded that it would be in the Company's interest to sell its entire holding in RMS should the RMS share price remain at such levels. As a consequence, the remainder of the holding was sold in the market as announced to the market on 18 November 2020. As stated on that date, the Board will consider a variety of options for the use of the net proceeds and inform shareholders in due course and as appropriate. The gross proceeds from the sale of RMS shares were £17.42 million. The Board is currently consulting its advisers in order to ascertain what the net proceeds are expected to be taking into account the level of any tax payable and will inform shareholders in due course. Details of the Company's investing policy can be found on the Company's website at hxxps://braveheartgroup.co.uk/investor-relations/investing-policy/. For further information: Braveheart Investment Group plc Tel: 01738 587555 Vivian Hallam, Director Allenby Capital Limited (Nominated Adviser and Joint Broker) Tel: 020 3328 5656 David Worlidge / James Hornigold Peterhouse Capital Limited (Joint Broker) Tel: 020 7469 0936 Heena Karani / Lucy Williams
Remote Monitored Systems share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
RMS
Remote Mon..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201128 17:16:43